Angela L. Alt

616 citations
6 papers · 431 indexed · h-index 3
Topics
Renal cell carcinoma treatment (3 papers)Urinary Tract Infections Management (2 papers)Bacterial Identification and Susceptibility Testing (2 papers)
Partner nations
United States

In The Last Decade

Angela L. Alt

6 papers receiving 423 citations

Peers

Angela L. Alt
Comparison fields: 5 of 51
  • Pulmonary and Respiratory Medicine 347
  • Molecular Biology 213
  • Cancer Research 133
  • Surgery 128
  • Oncology 112
Replace Danielo Garcia de Freitas with:
Danielo Garcia de Freitas United States
Maximiliano Sorbellini United States
Bertrand Dufour France
Etsuji Nakano Japan
Ujwal Yanala United States
Johanna Jesche Austria
Timothy Judge United States
Kim L. Wang United States
Atsushi Takise Japan
Ebru Ünsal Türkiye
Angela L. Alt relative to Danielo Garcia de Freitas United States Danielo Garcia de Freitas's profile →
Citations per field
00.5×4.3×
Danielo Garcia de Freitas · 1×
Citations per year

Countries citing papers authored by Angela L. Alt

Since Specialization
Citations

This map shows the geographic impact of Angela L. Alt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela L. Alt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela L. Alt more than expected).

Fields of papers citing papers by Angela L. Alt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela L. Alt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela L. Alt. The network helps show where Angela L. Alt may publish in the future.

Co-authorship network of co-authors of Angela L. Alt

This figure shows the co-authorship network connecting the top 25 collaborators of Angela L. Alt. A scholar is included among the top collaborators of Angela L. Alt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela L. Alt. Angela L. Alt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 299
2 106
3 22
4 1
5 1
6 2

About Angela L. Alt

Angela L. Alt is a scholar working on Clinical Biochemistry, Biotechnology and Infectious Diseases, having authored 6 papers that have together received 431 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (3 papers), Urinary Tract Infections Management (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (347 citations), Cancer Research (133 citations) and Oncology (112 citations). Angela L. Alt has collaborated with scholars based in United States. Frequent co-authors include Christine M. Lohse, Bradley C. Leibovich, Brian A. Costello, Michael L. Blute, Stephen A. Boorjian, Simon P. Kim, Christopher Weight, John C. Cheville, Cristine Allmer and Stephen A. Kramer. Their work appears in journals such as Cancer and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026